Research Grade Anti-Human CD30/CD16 Antibody (AFM13)

Anti-Human CD30/CD16 Antibody (AFM13) ( HB038036 ) is a research-grade recombinant antibody targeting CD30L . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns.

Спецификация

Species reactivity	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Form	Liquid
Storage	-20℃
Product category‌	Biosimilar
Target	CD30L receptor, Ki-1 antigen, CD30, TNFRSF8, D1S166E, Tumor necrosis factor receptor superfamily member 8, Lymphocyte activation antigen CD30, CD16a, CD16A, FCGR3A, Fc-gamma RIII-alpha, FcRIIIa, IgG Fc receptor III-2, Low affinity immunoglobulin gamma Fc region receptor III-A, IGFR3, CD16a antigen, Fc-gamma RIII, FCGR3, Fc-gamma RIIIa, FCG3, FcRIII, FcR-10
Accession	P28908 & P08637
Host species	Humanized

Информация для заказа

Область использования: Антитела Puda	Производство:	Puda Scientific
	Метод:	Иммуногистохимия
	Объем:	1mg
	Кат. номер:	PD-A26-470-100
Цена (с НДС 22%):	по запросу	В корзину
Наименование: Research Grade Anti-Human CD30/CD16 Antibody (AFM13). Примечание: